Clinical Trial Update: Study of Oral Fampridine-SR in Multiple Sclerosis [Phase 3]

View source ↗

Summary

Phase 3 trial results for oral fampridine-SR in multiple sclerosis have been completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Fampridine-SR (fampridine)

Snippet

Sponsor: Acorda Therapeutics | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2011-05-06